1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and under Sponsor: Pharmaceutical / Industry Protocol IDs: MT103-205, 2010-024264-18, NCT01471782
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MT103-203, NCT01207388
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MT103-211, 2011-002257-61, NCT01466179
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: MT103-208, 2011-005781-38, NCT01741792
|